Please read and agree to the
terms and conditions
of this site.
I agree
Medical Technology
/tech
Clear filters and search
Format
photo
2
×
Tags
alnylam pharmaceuticals
2
×
boston blog main
2
×
boston top stories
clinical trials
deals
2
×
fda
life sciences
national blog main
national top stories
new york blog main
new york top stories
regeneron pharmaceuticals
rna interference
alirocumab
ambys medicines
amgen
amicus therapeutics
ampio pharmaceuticals
angelman syndrome
athenex
biomarin pharmaceutical
biotech
bluebird bio
boulder/denver blog main
boulder/denver top stories
centers for medicare & medicaid services
chris collins
competitive generic therapy
cystic fibrosis
detroit blog main
detroit top stories
evolocumab
gene therapy
gout
hemophilia
inclisiran
indiana blog main
indiana top stories
innate immunotherapeutics
ironwood pharmaceuticals
What
drug
fda
2
×
acquire
agreed
aren’t
billion
bio
brings
cash
cholesterol
company
compound
deal
developers
drugs
gene
help
imminent
long
medco
medicare
medicines
moves
new
news
noteworthy
novartis
patients
poised
prices
ready
road
roundup
rulings
separate
therapy
they’ll
wave
winding
Language
unset
Current search:
photo
×
fda
×
" boston blog main "
×
deals
×
" alnylam pharmaceuticals "
×
@xconomy.com
4 years ago
Novartis to Acquire MedCo and FDA-Ready Cholesterol Drug for $9.7B
@xconomy.com
5 years ago
Bio Roundup: Medicare Drug Prices, FDA Moves, Gene Therapy News & More
